Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia Scarisbrick, Henry K. Wong, Maxime Battistella et al.|Journal of Clinical Oncology|2015Cited by 419
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)Nicolaus Kröger, Théo de Witte, Simona Iacobelli et al.|Journal of Clinical Oncology|2017Cited by 248
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumPietro Quaglino, C. Ram‐Wolff, Milena Maule et al.|Annals of Oncology|2017Cited by 136
Primary cutaneous B‐cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markersMarco Lucioni, Marco Paulli, Emilio Berti et al.|Cancer Medicine|2016Cited by 46
9 Clinical and endocopic improvement following hemopoietic stem cell transplantation in the ASTIC trialC J Hawkey, Séverine Vermeire, Matthieu Allez et al.|Journal of Crohn s and Colitis|2013Cited by 11